A new antiviral defense system discovered by Columbia scientists could be adapted in the future into a gene editor that slows down aging in our cells ...

October 12, 2026) - Frost & Sullivan officially released the 2026 Global Gene Therapy Industry Development Blue Book in October 2026, in collaboration with industry partners. The report systematically ...

Oxford Nanopore Technologies (LSE:ONT) took part in inaugurating the BRIC-CDFD–Oxford Nanopore Technologies India Genomics ...

Researchers have discovered a bacterial antiviral defense system, DRT10, that synthesizes tandem-repeat DNA through a ...

Scientists are highlighting long non-coding RNAs (lncRNAs) as promising targets in the effort to overcome one of cancer treatment's most persistent challenges: therapeutic resistance.

Oxford biotech secures $47 million to scale cell-based mRNA manufacturing, with an eye on therapies that require repeated ...

A research team led by professor Chan Kui-ming from the Department of Biomedical Sciences at CityUHK discovered that H2BE113K ...

Scientists have long sought to understand the complex origins of intelligent life. It remains unclear how biological systems ...

Amsbio has expanded its range of high-quality FFPE tissues and controls designed to support biomarker discovery, ...

Researchers have identified a gene that combines characteristics never before seen together in a single gene. • This "jumping gene," which also plays a role in brain function, can copy and insert ...

Neeraj Lal and Kavita Rangan among 42 recipients of federal support for early-career biomedical research projects.

Duke researchers led by Bruce Sullenger, PhD, have developed both the first fast-acting, synthetic blood thinner that’s just ...